The manufacturer cash route is NovoCare self-pay: about $349/month for maintenance-dose injectable Wegovy, with a $199/month introductory price for the first fill(s). The oral Wegovy tablet (FDA-approved December 2025) is the lowest-cost brand option, starting around $149/month. Both are well under the ~$1,349/month retail list price you would pay at a pharmacy counter with no program.
The Wegovy Savings Card can drop the copay to $0–$25/month, but it only works with commercial insurance that covers Wegovy — it does nothing if you are uninsured. Compounded semaglutide via licensed telehealth can run from about $69/month but is not FDA-approved as a finished drug.
Enroll or check current cash pricing at novocare.com or 1-888-693-6489. Prices are estimates as of July 2026 and change without notice; the introductory vs. maintenance distinction matters, so confirm which tier applies to your dose.